ACADIA PHARMACEUTICALS INC. (ACAD)

Import this data to Google Sheets with:

=jivedata("ACAD","financials")

Full statements spill as a table. For one cell: =jivedata("ACAD","Revenue") or =jivedata("ACAD","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

ACADIA PHARMACEUTICALS INC.

ACAD • CIK 0001070494

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenues	$726,437	—	—	$726,437
Revenue from Contract with Customer, Excluding Assessed Tax	$726,437	$957,797	$1,071,505	$1,138,644
Cost of Goods and Services Sold	$41,638	$81,841	$88,998	$100,979
Gross Profit	$684,799	—	—	$684,799
Selling, General and Administrative Expense	$406,559	$488,428	$548,894	$620,288
Research and Development Expense	$351,619	$303,249	$328,802	$331,009
Operating Income (Loss)	$-73,379	$230,794	$104,811	$86,368
Interest Income (Expense), Nonoperating, Net	$17,234	$25,458	$31,722	$32,623
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-51,036	$258,075	$138,904	$121,368
Income Tax Expense (Benefit)	$10,250	$31,624	$-252,096	$-259,116
Net Income (Loss) Attributable to Parent	$-61,286	$226,451	$391,000	$380,484
Net Income (Loss) Available to Common Stockholders, Basic	—	$226,451	$391,000	$380,484

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Assets	$748,956	$1,187,756	$1,564,195	$1,742,900
Liabilities	$317,201	$454,963	$336,805	$436,291
Assets, Current	$616,125	$938,318	$1,062,113	$1,224,545
Cash and Cash Equivalents, at Carrying Value	$188,657	$319,589	$177,695	$384,985
Accounts Receivable, after Allowance for Credit Loss, Current	$98,267	$98,739	$121,457	$150,642
Inventory, Net	$40,447	$91,690	$111,374	$108,673
Property, Plant and Equipment, Net	$4,612	$4,215	$7,511	$17,107
Property, Plant and Equipment, Gross	$14,168	$14,432	$16,995	$16,995
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$9,556	$10,217	$9,484	$9,484
Operating Lease, Right-of-Use Asset	$51,855	$46,571	$47,354	$69,424
Deferred Tax Assets, Net of Valuation Allowance	$6,800	$8,700	$39,400	$39,400
Other Assets, Noncurrent	$476	$359	$3,896	$3,550
Liabilities, Current	$254,254	$394,870	$277,114	$361,436
Accounts Payable, Current	$17,543	$16,192	$10,903	$44,566
Accrued Liabilities, Current	$236,711	$378,678	$266,211	$316,870
Stockholders' Equity Attributable to Parent	$431,755	$732,793	$1,227,390	$1,306,609

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Cash Provided by (Used in) Operating Activities	$16,702	$157,719	$109,836	$160,319
Net Cash Provided by (Used in) Investing Activities	$31,998	$-30,538	$-302,564	$-77,469
Net Cash Provided by (Used in) Financing Activities	$25,129	$6,845	$49,883	$46,814
Payments to Acquire Property, Plant, and Equipment	$50	$523	$4,690	$14,694

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("ACAD","financials")

Full statements spill as a table. For one cell: =jivedata("ACAD","Revenue") or =jivedata("ACAD","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.